Literature DB >> 336866

Kinetics and mechanisms of drug action of microorganisms XXIII: microbial kinetic assay for fluorouracil in biological fluids and its application to human pharmacokinetics.

E R Garrett, G H Hurst, J R Green.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 336866     DOI： 10.1002/jps.2600661019

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN： 0022-3549            Impact factor:   3.534


× No keyword cloud information.
  10 in total

1.  High volume intraperitoneal chemotherapy ("belly bath") for ovarian cancer. Pharmacologic basis and early results.

Authors:  R B Jones; C E Myers; A M Guarino; R L Dedrick; S M Hubbard; V T DeVita
Journal:  Cancer Chemother Pharmacol       Date:  1978       Impact factor: 3.333

Review 2.  Dose-dependent pharmacokinetics and cancer chemotherapy.

Authors:  G Powis; M M Ames; J S Kovach
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333

3.  Nonlinear pharmacokinetics for the elimination of 5-fluorouracil after intravenous administration in cancer patients.

Authors:  B J McDermott; H W van den Berg; R F Murphy
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

4.  Scaling the time-course of myelosuppression from rats to patients with a semi-physiological model.

Authors:  Lena E Friberg; Marie Sandström; Mats O Karlsson
Journal:  Invest New Drugs       Date:  2009-08-27       Impact factor: 3.850

5.  Regional and systemic serum concentrations of 5-fluorouracil after portal and intravenous infusion: an experimental study in dogs.

Authors:  B G Gustavsson; A Brandberg; C G Regårdh; O E Almersjö
Journal:  J Pharmacokinet Biopharm       Date:  1979-12

6.  Nonlinear pharmacokinetic characteristics of 5-fluorouracil (5-FU) in colorectal cancer patients.

Authors:  L J Schaaf; B R Dobbs; I R Edwards; D G Perrier
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

7.  Plasma levels of 5-fluorouracil after oral and intravenous administration in cancer patients.

Authors:  R E Finch; M R Bending; A F Lant
Journal:  Br J Clin Pharmacol       Date:  1979-06       Impact factor: 4.335

8.  Computer modeling of the pharmacokinetics of Fluorouracil and thymine and their kinetic interaction in normal dogs.

Authors:  J M Covey; J A Straw
Journal:  Pharm Res       Date:  1985-09       Impact factor: 4.200

Review 9.  Clinical pharmacology of 5-fluorouracil.

Authors:  R B Diasio; B E Harris
Journal:  Clin Pharmacokinet       Date:  1989-04       Impact factor: 6.447

10.  New insights into the mechanisms underlying 5-fluorouracil-induced intestinal toxicity based on transcriptomic and metabolomic responses in human intestinal organoids.

Authors:  Daniela Rodrigues; Terezinha de Souza; Luke Coyle; Matteo Di Piazza; Bram Herpers; Sofia Ferreira; Mian Zhang; Johanna Vappiani; Daniel C Sévin; Attila Gabor; Anthony Lynch; Seung-Wook Chung; Julio Saez-Rodriguez; Danyel G J Jennen; Jos C S Kleinjans; Theo M de Kok
Journal:  Arch Toxicol       Date:  2021-06-20       Impact factor: 5.153
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.